Chargement en cours...
Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea
Irritable bowel syndrome (IBS) is one of the most common disorders of the gut-brain axis, which affects approximately 4% of the global population. The Rome IV criteria define IBS as chronic or recurrent abdominal pain associated with altered bowel habits. Patients can be categorized in four subtypes...
Enregistré dans:
| Publié dans: | Front Pharmacol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7935509/ https://ncbi.nlm.nih.gov/pubmed/33679391 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.629026 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|